Enhancing the efficacy of viral vector blood-stage malaria vaccines
<p>Replication-deficient adenovirus (Ad) and modified vaccinia virus Ankara (MVA) vectors expressing single Plasmodium falciparum antigens can induce potent T cell and antibody responses and have entered clinical testing using a heterologous prime-boost immunisation approach (Ad_MVA). This the...
Huvudupphovsman: | |
---|---|
Övriga upphovsmän: | |
Materialtyp: | Lärdomsprov |
Språk: | English |
Publicerad: |
2011
|
Ämnen: |